Eliyahou Et Al Harari Acquires 81,300 Shares of CapsoVision (NASDAQ:CV) Stock

CapsoVision, Inc. (NASDAQ:CV) major shareholder Eliyahou Et Al Harari acquired 81,300 shares of the firm’s stock in a transaction on Wednesday, July 8th. The stock was purchased at an average cost of $6.09 per share, for a total transaction of $495,117.00. Following the completion of the acquisition, the insider owned 3,282,051 shares in the company, valued at approximately $19,987,690.59. This represents a 2.54% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s shares are required to disclose their sales and purchases with the SEC.

Eliyahou Et Al Harari also recently made the following trade(s):

• On Friday, June 26th, Eliyahou Et Al Harari bought 13,850 shares of CapsoVision stock. The stock was acquired at an average cost of $7.35 per share, with a total value of $101,797.50.

CapsoVision Stock Performance

Shares of CV stock traded up $0.22 on Friday, hitting $5.99. The company’s stock had a trading volume of 87,049 shares, compared to its average volume of 234,181. CapsoVision, Inc. has a fifty-two week low of $3.43 and a fifty-two week high of $15.37. The stock’s 50 day moving average is $6.87 and its 200-day moving average is $6.71. The company has a market capitalization of $299.26 million and a PE ratio of -2.56.

CapsoVision (NASDAQ:CV) last announced its earnings results on Thursday, May 14th. The company reported ($0.15) earnings per share (EPS) for the quarter. The business had revenue of $2.79 million for the quarter.

Wall Street Analyst Weigh In

CV has been the subject of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of CapsoVision in a research report on Monday, June 29th. Benchmark dropped their target price on shares of CapsoVision from $14.00 to $10.00 and set a “speculative buy” rating for the company in a research report on Friday, March 27th. One equities research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, CapsoVision currently has an average rating of “Moderate Buy” and an average price target of $8.50.

Institutional Trading of CapsoVision

Large investors have recently bought and sold shares of the business. Geode Capital Management LLC lifted its holdings in shares of CapsoVision by 34.1% in the fourth quarter. Geode Capital Management LLC now owns 154,264 shares of the company’s stock worth $1,649,000 after acquiring an additional 39,231 shares during the last quarter. State Street Corp grew its holdings in shares of CapsoVision by 340.7% during the 4th quarter. State Street Corp now owns 85,929 shares of the company’s stock valued at $919,000 after purchasing an additional 66,429 shares during the last quarter. Bank of New York Mellon Corp acquired a new position in CapsoVision during the 1st quarter worth approximately $359,000. Citadel Advisors LLC bought a new position in CapsoVision in the 3rd quarter valued at approximately $115,000. Finally, Bank of America Corp DE grew its stake in shares of CapsoVision by 528.9% during the first quarter. Bank of America Corp DE now owns 22,238 shares of the company’s stock worth $162,000 after buying an additional 18,702 shares during the last quarter.

About CapsoVision

CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. The company’s flagship product, the CapsoCam® Plus System, features a swallowable, tether-free capsule equipped with four side-viewing cameras that capture high-resolution, 360-degree images of the small intestine. By storing images internally rather than transmitting data wirelessly, CapsoCam Plus enables patients to maintain normal daily activities during the procedure and reduces the risk of signal loss or image drop-out.

In addition to its capsule hardware, CapsoVision offers CapsoCloud®, a secure, cloud-based platform that streamlines image retrieval, storage and reporting.